UNICHEMLAB — Unichem Laboratories Balance Sheet
0.000.00%
- IN₹32.77bn
- IN₹36.20bn
- IN₹21.11bn
- 28
- 42
- 28
- 20
Annual balance sheet for Unichem Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,171 | 3,761 | 1,854 | 1,582 | 1,167 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5,007 | 6,460 | 7,487 | 8,184 | 8,965 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 13,773 | 16,449 | 15,885 | 17,433 | 20,295 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14,464 | 14,823 | 14,026 | 13,172 | 13,100 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 31,257 | 33,188 | 31,930 | 32,750 | 35,694 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,058 | 5,521 | 6,396 | 7,376 | 9,920 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 5,689 | 7,004 | 7,577 | 8,367 | 11,188 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 25,568 | 26,184 | 24,353 | 24,383 | 24,506 |
| Total Liabilities & Shareholders' Equity | 31,257 | 33,188 | 31,930 | 32,750 | 35,694 |
| Total Common Shares Outstanding |